March 4, 2011: Notice on FDA Announcement Regarding TOPAMAX® (topiramate) The Food and Drug Administration (FDA) has announced increased precautions on the use of TOPAMAX in pregnancy. As the makers of TOPAMAX, Ortho-Mc

First Page		Document Content
Date: 2011-03-04 17:02:38 Anticonvulsants Topiramate Treatment of bipolar disorder Pharmacology Ortho-McNeil-Janssen Ortho-McNeil Pharmaceutical Food and Drug Administration Pregnancy Johnson & Johnson Medicine Chemistry		March 4, 2011: Notice on FDA Announcement Regarding TOPAMAX® (topiramate) The Food and Drug Administration (FDA) has announced increased precautions on the use of TOPAMAX in pregnancy. As the makers of TOPAMAX, Ortho-Mc Add to Reading List Source URL: www.topamax.com Download Document from Source Website File Size: 216,00 KB Share Document on Facebook

	Johnson & Johnson logo_bw DocID: 1um8m - View Document
	Guidance on the SEP for Consumers without FFM Coverage due to Failure to File & Reconcile DocID: 1qVXr - View Document
	CY16 Employee & Retiree Rates w Subsidy DocID: 1qNaT - View Document
	Fiscal & Administrative Manager Band 2 DocID: 1qF4t - View Document
	Jonhson & Johnson Credo DocID: 1qkqB - View Document